(Q28566456)

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

The paradox of dysfunctional high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

The effect of lipoproteins on the development and progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

NADPH oxidases in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Novel NAD(P)H oxidases in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Oxidative stress in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Mechanism of action of niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Non-traditional cardiovascular disease risk factors in end-stage renal disease: oxidate stress and hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Oxidative stress and antioxidant treatment in hypertension and the associated renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Niacin therapy in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Reverse cholesterol transport pathway in experimental chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Role of immunocompetent cells in nonimmune renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Oxidative stress in uremia: nature, mechanisms, and potential consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009

Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00126.2009